Incentives for orphan drug research and development in the United States

BACKGROUND: The Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare diseases and conditions. This study analyzed the characteristics of OD designations, approvals, sponsors, and evaluated the effective patent and market exclusivity l...

Descripción completa

Detalles Bibliográficos
Autores principales: Seoane-Vazquez, Enrique, Rodriguez-Monguio, Rosa, Szeinbach, Sheryl L, Visaria, Jay
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631478/
https://www.ncbi.nlm.nih.gov/pubmed/19087348
http://dx.doi.org/10.1186/1750-1172-3-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631478/
https://www.ncbi.nlm.nih.gov/pubmed/19087348
http://dx.doi.org/10.1186/1750-1172-3-33

Ejemplares similares